VVOS — Vivos Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $7.16m
- $4.55m
- $13.80m
- 36
- 24
- 20
- 16
Annual cashflow statement for Vivos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.8 | -12.1 | -20.3 | -23.8 | -13.6 |
| Depreciation | |||||
| Non-Cash Items | 2.13 | 6.09 | 3.79 | 1.88 | -1.85 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.53 | -0.431 | 0.028 | 1.71 | 2.86 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -5.34 | -5.68 | -15.7 | -19.6 | -11.9 |
| Capital Expenditures | -0.176 | -0.12 | -2.4 | -0.924 | -0.803 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.262 | 0 | -0.212 | 0 | -0.05 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.086 | -0.12 | -2.61 | -0.924 | -0.853 |
| Financing Cash Flow Items | -0.16 | -0.245 | -2.24 | 0 | -1.08 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.47 | 23.5 | 24.2 | 0 | 10.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.785 | 17.7 | 5.82 | -20.5 | -1.88 |